Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
casr.png
 
 
 
Hauptnavigation
  • Home
  • General Information
    • Newsletter
    • Outreach
    • Recruitment
    • Meetings
    • Publications
    • Awards
    • Previous Project Multifaceted CaSR
    • Contact
  • Projects
    • Project 1 - CaSR-mediated signalling in colonocytes
    • Project 2 - Evaluation of CaSR - based therapeutics in prevention of tumourigenesis and metastatic potential in colorectal cancer
    • Project 3 - Role of the CaSR in inflammatory lung diseases
    • Project 4 - Evaluation of CaSR-targeted drugs for the treatment of neuroblastoma
    • Project 5 - Delineation of CaSR signalling in primary cells and cell lines with native receptor expression
    • Project 6 - Role of the calcium-sensing receptor (CaSR) in glucose homeostasis
    • Project 7 - Cell-specific CaSR signaling
    • Project 8 - Targeting CaSR in human skeletal muscle cells to delay sarcopenia development
    • Project 9 - Evaluation of CaSR-targeted drugs for the treatment of diabetes mellitus
    • Project 10 - Role of the CaSR in early bone metastasis of breast cancer cells and evaluation of CaSR - based therapeutics in prevention or delay of metastasis formation
    • Project 11 - Ligand-biased G-protein activation by CaSR
    • Project 12 - The role of CaSR in AD pathomechanisms
    • Project 13 - In silico analysis of CaSR-ligand interaction
    • Project 14 -Generation, validation and application of algorithms for tissue segmentation used in advanced tissue cytometry
  • People
    • ESR Fellows
    • Academic Beneficiaries
    • Non-academic Beneficiaries
    • Partner Organisations
    • Coordination Team
    • Advisory Board
  • Training
    • Secondments
    • E-Learning Modules
    • 1st ETN School: CaSR: Molecular and clinical aspects
    • 2nd ETN School: Translational drug Research
    • 3rd ETN School: Introduction to Academic Teaching
    • 4th ETN School: Self-presentation & Communication
    • 5th ETN School: Research, Innovation Entrepreneurship
 
Projects / Project 7 - Cell-specific CaSR signaling
 
Subnavigation
  • Project 1 - CaSR-mediated signalling in colonocytes
  • Project 2 - Evaluation of CaSR - based therapeutics in prevention of tumourigenesis and metastatic potential in colorectal cancer
  • Project 3 - Role of the CaSR in inflammatory lung diseases
  • Project 4 - Evaluation of CaSR-targeted drugs for the treatment of neuroblastoma
  • Project 5 - Delineation of CaSR signalling in primary cells and cell lines with native receptor expression
  • Project 6 - Role of the calcium-sensing receptor (CaSR) in glucose homeostasis
  • Project 7 - Cell-specific CaSR signaling
  • Project 8 - Targeting CaSR in human skeletal muscle cells to delay sarcopenia development
  • Project 9 - Evaluation of CaSR-targeted drugs for the treatment of diabetes mellitus
  • Project 10 - Role of the CaSR in early bone metastasis of breast cancer cells and evaluation of CaSR - based therapeutics in prevention or delay of metastasis formation
  • Project 11 - Ligand-biased G-protein activation by CaSR
  • Project 12 - The role of CaSR in AD pathomechanisms
  • Project 13 - In silico analysis of CaSR-ligand interaction
  • Project 14 -Generation, validation and application of algorithms for tissue segmentation used in advanced tissue cytometry


Inhaltsbereich

Project 7 - Cell-specific CaSR signaling

Host Institution: University of Manchester
» Info

Hypothesis: CaSR signalling involves pleiotropic interactions between multiple G protein pathways with the potential for cell-specific competition between these effectors known as conditional efficacy.

Objectives:To determine the relative stoichiometry of CaSR partner/effector proteins between different cell-types and then relate these to their differential responsiveness. ESRUM will use HEK-293, endothelial (HUVEC), parathyroid (PTH-C1), and colonic cells to compare CaSR signalling responses among cell types [Ca2+i and a panel of kinase effectors]. Phosphorylation of the CaSR on T888 is a crucial signalling control. Therefore, ESRUM will compare the relative activities of gain-of-function (T888A) and loss-of-function (T888D) CaSR mutants between the 4 cell types in order to identify cell-specific differences in the consequence of CaSRT888 phosphorylation. Finally, ESRUM will examine the relative effects of altering intracellular cAMP concentration or relative expression of particular effector proteins (Gq/11, Gi/o, G12/13, rho & rho-GEF) in the different cells to show how these alter CaSR signalling dynamics.

 
Drucken
 

Quick Links

 
-- News Archive
-- Previous Project Multifaceted CaSR
-- Papers authored by the Multifaceted CaSR Fellows
-- Contact
 
 

Featured

 
 
 
 
 
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact